Product Description: Ozuriftamab is a naked human IgG1 kappa antibody of receptor tyrosine kinase-like orphan receptor 2 ROR2, can be used to synthesis ADC[1].
Applications: Cancer-Kinase/protease
Formula: N/A
References: [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 35, No. 4, 2021.
CAS Number: 2460399-44-2
Molecular Weight: N/A
Compound Purity: 98.40
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: ADC Antibody